INTRODUCTION
Understanding why we eat and the motivational factors driving food choices is important for addressing the epidemics of obesity, diabetes, and cardiovascular disease, as food intake is a significant factor impacting the development and treatment of these disorders. Eating behavior is a complex interplay of physiological, psychological, social, and genetic factors that influence meal timing, quantity of food intake, food preference, and food selection. Active research involving the genetics of taste, food preference, pathological eating behaviors, meal size, and meal selection is rapidly expanding our understanding of how and why we eat. More recently, neural imaging modalities, specifically functional magnetic resonance imaging (FMRI), has emerged as a modality to effectively study eating behavior and genetics in fascinating ways. Reviewed here is the current knowledge of the genetic influences of eating behavior, with particular emphasis on the genetics of taste, meal size and selection, and the emerging use of FMRI as it applies to imaging the neurophysiological response to food stimuli. The primary focus of this review is on obesity as a consequence of eating behavior, but other pathological disorders of eating behavior, including anorexia nervosa and bulimia nervosa, also have strong genetic, psychological, and environmental components. 1 The rapid rise in obesity and associated comorbidities (metabolic syndrome, coronary artery disease, sleep apnea, skeletal disorders, hyperlipidemia, and hypertension) over the past 30 years has led to the present urgency of efforts to obtain a more complete understanding of the pathophysiology of obesity. The study of eating behavior attempts to define eating patterns and food preferences, to explain why there is gravitation toward specific behaviors and food choices, and aims to develop approaches to bring about effective changes in modifiable behaviors. Knowledge of the biological mechanisms guiding eating behavior can provide effective treatment targets for obesity and associated disorders.
Rare monogenic genetic disorders involving hyperphagia and obesity have been identified. 2 Resulting from a deletion of the11-13q region of chromosome 15, Prader Willi (PW) is characterized by hypotonia and poor feeding in early infancy, cognitive, motor, and behavioral impairment, followed by insatiable hunger and the development of morbid obesity and diabetes during childhood. 3 PW patients rarely survive beyond 25-30 years of age; the cause of death is often related to diabetes and cardiac failure. Monosomy 1p36 has also been associated with obesity and hyperphagia in a PW-negative cohort. 4 Individuals with loss-of-function mutations of the leptin (LEP) gene on chromosome 7q31.3, or its receptor (LEPR) also display abnormal eating behavior and develop early-onset morbid obesity. 5, 6 Leptin replacement can improve satiety and promote weight loss in leptin-deficient individuals. 7 Leptin promotes amelanocyte-stimulating hormone(a-MSH) synthesis, which promotes satiety.
8 a-MSH is bound by the melanocortin 4 receptor (MCR4) protein. MC4R mutations are associated with early-onset obesity. 9, 10 Discoveries of the genes and their respective proteins involved in these rare forms of obesity help shed light on the pathways involved in regulating eating behavior and energy homeostasis. Although important, monogenic forms of obesity account for less than 10% of today's obesity epidemic.
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Although rare genetic mutations cause dramatic hyperphagia, most of the common genetic variants have smaller effect sizes. The risk of obesity, metabolic syndrome, and other complications is increased by a variety of common genetic variants, and many of these are associated with specific eating behaviors. Research tools used to measure eating behavior include food logs, observation, food preference flash cards, labeled scaling, and, more recently, FMRI. A widely used research tool known as the three-factor questionnaire (TFQ) has been used to quantify eating behaviors in normal-weight and obese individuals as well as those with eating disorders. 12 This questionnaire uses a series of questions to measure three patterns of behavior: restraint, disinhibition, and hunger. High restraint and disinhibition scores are both positively correlated with BMI. 13, 14 Restraint is characterized by the intentional avoidance of certain foods in order to control body weight, and is measured by response to questions on the TFQ such as "I avoid certain foods because they make me fat. " Disinhibition is the tendency to overeat when surrounded by others who are overeating. Hunger measures the subjective sense of an individual's need to eat. Heritability and linkage analysis of eating behavior measured by the TFQ provides evidence that these behavior traits are heritable. 15, 16 Although much remains to be understood about the genes regulating these behaviors, genetic influence of disinhibition has been linked to neuromedin, a factor mediating satiety, in a French Canadian cohort and to TAS2R38, a bitter taste receptor, in a cohort of Amish women. 16, 17 GAD (glutamic acid decarboxylase) has also been linked to eating behavior. GAD decarboxylates glutamate into GABA (g-aminobutyric acid), a major inhibitory neurotransmitter in the brain. Two specific GAD variants, rs7908975 and rs992990, have been reported to be associated with disinhibition and disordered food intake, specifically, increased carbohydrate intake in women.
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GENETICS OF TASTE
Taste affects food preference and food intake, thereby directly influencing eating behavior. However, not all humans perceive taste in exactly the same way. The density of taste papillae on the tongue, genetic differences in taste receptors or sensitivity of taste receptors, constituents of saliva, and other factors all contribute to an individual's taste perception and subsequent food preferences. 19 Differences in taste papillae density impacts taste sensitivity and are thought to be genetically determined 20 ; however, the gene or genes responsible for this trait have yet to be identified. Differences in taste perception and preference influence food choices and have significant impact on nutrient and caloric intake.
Five tastes are recognized by humans: sweet, bitter, sour, salty, and umami (described as the taste of glutamate or the taste of amino acids and proteins). Food preference and intake is influenced by sweet and bitter taste. For example, individuals who possess enhanced perception of bitter taste tend to avoid certain foods, including specific fruit and vegetables. 21 Preference for sweet and high-fat food has been reported to decrease with increasing perception of bitter taste. [21] [22] [23] [24] Evidence suggest bitter tasting ability may be related to body mass index (BMI), adiposity, and risk factors for CVD, 25, 26 while the perceived sweetness of foods has been shown to be inversely correlated with BMI. 27 Bitter taste sensitivity has also been linked to height variations among children, suggesting this trait may influence food selection and impact growth rate. 28, 29 Individuals who are particularly sensitive to bitter compounds tend to avoid the bitter taste of beer and alcohol and avoid cigarette smoking as well. 25, 30 Bitter taste as well as preference for sweet and fat guide ingestive behaviors and have been linked to obesity; these food preference traits may, in part, be genetically determined.
Bitter, sweet, and umami tastes are mediated by G-protein-coupled receptors (GPCRs). Bitter taste receptors are encoded by 25-30 TAS2R genes, located on chromosomes 12p13, 7q34, and 5p15.31. The ligand specificity of TAS2Rs appears to be quite broad, consistent with their roles in detecting thousands of bitter-tasting compounds. 31 One of these, TAS2R38 has been extensively characterized in vitro, in vivo, and in human populations, and is responsive to the bitter stimuli phenylthiocarbamide, propylthiouracil (PROP), and to thiocyanates -bitter compounds found in brassia vegetables such as brussels sprouts and broccoli. Two common haplotypes of TAS2R38 have been shown to influence perception of bitter taste and are significantly related to differences in bitter taste sensitivity, 32 preference for sucrose and sweettasting foods and beverages, and to modestly lower the risk of type 2 diabetes among participants of the British Women's Heart and Health Study. 33, 34 While studies are not all in complete agreement, individuals most sensitive to the taste of PROP more often dislike bitter fruits and vegetables, such as grapefruit and kale. These low-energy foods may be replaced by more energy-dense foods among individuals more sensitive to bitter taste. 35 TAS2R38 haplotype has been suggested to be predictive of obesity 36 ; however, to date, studies involving large cohorts have failed to demonstrate convincing evidence for a direct relationship between TAS2R38 and BMI in spite of evidence that polymorphisms in this gene influence ingestive behavior. 37 The majority of TAS2R38 studies have been conducted in Caucasian populations; therefore, further research is necessary to determine how well current findings can be generalized to other ethnic populations.
TAS2R5, another bitter receptor, may be an important regulator of ingestive behavior. This gene resides in a region of chromosome 7 that is significantly associated with a quantitative phenotypic marker of alcohol dependence called ttth 1. Furthermore, a single nucleotide polymorphism (SNP) located within a linkage disequilibrium block that includes TAS2R5 accounts for this association. 38 A SNP in another chromosome 7 gene, TAS2R16, has been linked to alcohol dependence as well. 39 These findings suggest that genetic variation in TAS2R genes may be involved in regulating ingestive behaviors.
The receptors for sweet and umami taste are encoded by three TAS1R genes located on chromosome 1p36. Heteromeric TAS1R2:TAS1R3 taste receptors respond to sweet-tasting compounds such as sugars, highpotency sweeteners, and some D-amino acids, while TAS1R1:TAS1R3 heteromers comprise an umami taste receptor sensitive to L-amino acids. 31 Both subunits of the sweet taste receptor bind sugar ligands, though they do so with distinct affinities and ligand-dependent conformational changes. 40, 41 Although variability in both sweet and umami taste have been described, these traits are not as well defined as those of PROP tasting, and specific genetic variants responsible for variation in sweet and umami taste remain to be identified.
TAS1Rs and TAS2Rs are expressed in diverse tissue, including brain, adrenal gland, pancreas, small intestine, retina, skeletal muscle, salivary gland, and tongue. [42] [43] [44] Of particular interest is the observation that TAS1R and TAS2R receptors, as well as other proteins involved in taste transduction, are expressed in the gastrointestinal mucosa, where they modulate responses to ingested nutrients via glucagon-like peptide-1 (GLP-1), cholecystokinin (CCK), and gastric inhibitory polypeptide (GIP). 44, 45 GIP, GLP-1, and CCK regulate gut motility and appetite. Therefore, TAS1Rs and TAS2Rs may be integral to modulating both taste and ingestive behavior via mediating enteroendocrine secretion. Dotson et al. 46 demonstrated TAS2R9 to be involved in GLP-1 secretion, with a loss-of-function mutation in the gene resulting in attenuated GLP-1 response to agonist. In another study performed by Dotson et al., 17 genetic variation in TAS2R38 was shown to be associated with eating behavior in a cohort of Amish women. Genetic variation in TAS1Rs and TAS2Rs may impact eating behavior via altered taste perception as well as via alteration in neuroendocrine signals impacting satiety. The observation that these receptors are involved in both taste and secretion of the hormones involved in satiety tell us that these processes may be biologically entwined. Table 1 summarizes gene variants linked to eating behavior and taste.
MEAL SELECTION AND SIZE
Research into meal size and selection is especially complex as an individual's socioeconomic environment, learned eating behaviors, physiological conditions such as depression, and even medical treatments can all influence appetite and food selection, independent of genetics; however, meal quantity, frequency, and timing are thought to be, at least in part, under genetic control. The study of genetic variants in digestive neuroendocrine hormones, such as CCK, leptin, and ghrelin, are providing new insights into how these hormones and their genetic variants may be involved in pathways regulating appetite and eating behavior. 46 Lin (2005), 38 Hinrichs (2006) 39
Ghrelin, a 28-amino acid peptide, is primarily produced by the stomach and pancreas and is involved in promoting meal intake and hunger through receptors in the hypothalamus. 47 Plasma ghrelin levels rise pre-meal and are suppressed by food intake. 48 GHRL is located on chromosome 3. The gene product is involved in growth hormone release, and post-translational modifications yield the hormones ghrelin and obstatin. Obstatin opposes the effects of ghrelin and is responsible for satiety and decreasing food intake. 49 Many studies have been devoted to investigating GHRL variants with respect to obesity. A common variant, Leu72Met, has been associated with obesity, 50,51 metabolic syndrome, 52 and binge eating. 53 Leptin and CCK work in opposition to ghrelin to promote satiety. CCK is released in response to lipids and promotes rapid post-prandial satiety in contrast to the long-term action of leptin. 54 In a large case-control study of 17,000 obese and normal-weight women, three common leptin variants (rs4577902, rs2060736, and rs4731413), were associated with increased risk of extreme snacking behavior (top fifth percentile based on 11-question questionnaire), but not increased meal size. 55 CCK variants (rs6809785, rs7611677, rs6801844, and rs6791019) were found to be more associated with extreme meal size (top fifth percentile based on estimated portion sizes using 28 picture cards) but not increased snacking behavior in the same study. The results of this study suggest that genetic variation in genes encoding CCK and leptin may contribute to obesity risk by influencing satiety and may have independent effects. Additional studies are needed to further clarify the role of genetic variation in these genes to provide a better understanding of how they may modulate eating behavior.
FTO, fat mass and obesity-associated gene, has been highly associated with increased risk of obesity. 56 FTO is localized to chromosome 16 and is expressed in adipocytes, the pancreas, and the hypothalamus, particularly in regions known to regulate appetite. FTO may contribute to obesity by downregulating adipocyte production of leptin. 57 A common variant (rs9939609) is associated with adiposity, and possibly satiety responsiveness. den Hoed et al. 56 demonstrated the A allele of rs9939609 is associated with reduced post-prandial satiety and may also contribute to excess caloric intake in a study of men and women of Western European descent with BMIs ranging from 19 to 31 (5 of 62 subjects had a BMI >30). This study also analyzed post-prandial response to hunger and the interaction among variants in leptin, the leptin receptor, and methyltransferase genes. The authors concluded that the effect of the rs9939609 A allele on the postprandial response in hunger appears to be mediated by an epistatic interaction involving variants in a methyltransferase gene and the leptin receptor. In another study, Scottish children who were homozygous or heterozygous for the rs9939609 A allele also demonstrated increased energy intake without associated energy expenditure. Of interest, all the children ate approximately the same weight of food, but those children with the rs9939609 A allele consumed more energy-dense foods. 58 The authors of this study concluded that this FTO variant confers a predisposition to obesity and may play a role in the control of food intake and food choice, perhaps involving a hyperphagic phenotype or a preference for energy-dense foods. Tanofsky-Kraff 59 replicated these findings in a cohort of 289 children and adolescents, suggesting that FTO may indeed contribute to preference for higher fat intake and large meal size. Although provoking, these findings should be interpreted with some caution, as at least one study has shown rs9939609 not to be correlated with increased risk of obesity 60 ; however, the current accumulated evidence clearly implicates FTO as having a significant impact on food intake and obesity.
Genetic variations in FTO, leptin, the leptin receptor, and ghrelin, genes involved in the neuroregulation of food intake, appear to contribute to obesity risk by influencing satiety and hunger, and they may contribute to increased caloric intake. Larger and more genetically diverse cohorts need to confirm these observations. Functional studies of the impact of these variants on gene expression or action are also needed. Improving our understanding of the mechanisms whereby these genes interact and their potential molecular crosstalk may provide novel targets for developing treatments for individuals with reduced satiety in response to meals. Table 2 summarizes the current knowledge with respect to genetic variants linked to meal selection and size. Figure 1 depicts genes whose common variants have been implicated with eating behavior and obesity.
Functional magnetic resonance imaging
A variety of cognitive pathways are involved in motivation and control of eating behavior. The new use of neuroimaging techniques, specifically FMRI, to demonstrate specific neural reactions in response to food stimulus is revolutionizing the study of eating behavior. Other imaging techniques, such as positron emission tomography, have been previously used to investigate neural responses to taste and to identify neural pathways involved in eating behavior. 61 FMRI has previously been a well-established tool to identify pathology in studies of schizophrenia, 62 Alzheimer's disease, 63 and many other areas of neuroscience research. Nearly all FMRI studies utilize blood oxygen level dependence (BOLD) to identify areas in the brain that demonstrate increased glucose uptake and therefore increased activity in response to specific stimuli. Eating behavior research utilizing FMRI has focused on BOLD changes in specific brain regions in obese compared to normal-weight individuals.
Eating behavior studies utilizing FMRI have shown that a fasting state increases cortical activation among lean individuals, 64 increases preference for high-calorie foods in obese individuals, [64] [65] [66] and that obese men have attenuated post-prandial brain reactions to satiety that may explain excess caloric intake. 67 Ghrelin infusion in normal-weight volunteers produced increased BOLD response to food pictures in the amygdala, orbitofrontal cortex, anterior insula, and striatum, areas of the brain involved in activating ingestive behavior, and elicited increased self-reports of hunger. 68 Likewise, patients with lower leptin levels secondary to weight loss or secondary to genetic leptin deficiency have increased BOLD activity in brain areas involved in emotional, cognitive, and sensory control of food intake in response to food stimuli, which subsequently normalize with leptin infusion. 7, 69 Neurophysiologic processing in response to food is largely accomplished in the left hemisphere, specifically in the dorsal and ventral striatum, fusiform gyri, and insula, with the latter two known as the "primary gustatory complex. " 64 Feeding is associated with dopamine release, 70 and the amount of dopamine release positively correlates with perceived food pleasure. 71 Obese individuals have lower striatal concentrations of the D2 dopamine receptor, 71 which is a finding that suggests the lower concentrations of this G protein-coupled receptor may evoke overeating in obese individuals in order to produce a reward response. An alternative interpretation is that dopamine receptors may be downregulated in response to excessive food stimuli. Martin et al. 72 demonstrated that brain regions involved in pathways of food reward in obese individuals exhibited increased BOLD activation, specifically the limbic region and the prefrontal region, both of which have high concentrations of dopamine receptors. Obese individuals also had greater memory for foods in the fasted state. Fasted obese individuals have also been shown to exhibit higher pre-meal activation of the anterior cingulated cortex and medial prefrontal cortex, areas of the brain implicated in motivational processing. 72 These findings have been supported by Haase et al. 73 who also noted increased BOLD activation in the prefrontal and limbic regions in response to taste stimuli among fasting obese individuals. Although these studies are promising, they remain limited by small numbers of Ghrelin:
Increased risk of binge eating 53 Impacts cognitive behavior Impacts food selection Figure 1 Genes identified with common variants influencing eating behavior with potential impact on obesity.
participants and many of these studies have focused largely on obese women. Because magnetic resonance imaging equipment can withstand limited study subject body weight, studies using this tool are restricted to the inclusion of subjects whose body weights can be accommodated by the equipment. Despite these limitations, FMRI has been used successfully to shed light on the pathways involved in eating behavior and to demonstrate important functional differences in brain imaging among obese individuals. Of particular interest are innovative studies combining genetic studies with FMRI to investigate eating behavior. Combining these modalities may help uncover interrelationships among genetics and the neurophysiologic pathways involved in food response and eating behavior. Felsted et al. 74 hypothesized that polymorphisms in genes involved in the neurophysiology of feeding and reward processing would demonstrate differential responses in brain regions known to be involved in food reward. They chose to investigate a particular variant, TAQ1A, 75 a restriction fragment length polymorphism located on ANKK1 (ankyrin repeat and protein kinase domaincontaining protein 1), a regulatory gene downstream of the dopamine D2 receptor, and to perform functional magnetic resonance imaging to measure neural response to the ingestion of palatable and caloric milkshakes in 26 healthy subjects (24 women and 2 men). The TAQ1A variant has previously been implicated as having a role in obesity and eating behavior, particularly with respect to the relationship between neural response to food and prospective weight gain. 71 Individuals with the A1/A1 or A1/A2 allele of TAQ1A are more likely to be obese and have 30-40% fewer dopamine receptors. 71 In the Felsted study, either a milkshake or a tasteless, odorless liquid was randomly dripped into the mouths of the subjects while the subjects rested within the MRI device. The investigators attempted to control for confounding variables that may influence food response. Participants were all matched for BMI, hunger rating, and for psychological factors such as impulsivity, addiction, and eating style assessed through a variety of psychological and food intake surveys. No subject reported taking prescriptions or over-the-counter medications. This study elegantly demonstrated that individuals possessing the A1 TAQ1A allele had decreased BOLD response to a milkshake in midbrain, thalamus, and orbital frontal cortex regions of the brain, all of which are involved in regulating eating behavior, even though all participants rated similarly the perceived pleasantness and familiarity of the milkshake. 74 These findings suggest that individuals possessing the A1 allele might be predisposed to overeating as they experience attenuated neural reward response to food. Whether this variation in response to food stimulus is due to a diminished number of dopamine receptors is yet to be determined. This study is, to our knowledge, the first to directly demonstrate that individuals with a specific genetic variant have measurable neural changes directly correlated with eating behavior in response to a food stimulus. These findings provide hope for the future development of treatment aimed at modulating foodinduced sensitivity to pleasure and satiety centers in genetically susceptible individuals.
CONCLUSION
Eating behavior is a complex trait with both genetic and environmental influences. While sequencing an individual's entire genome is expensive, this process will become less costly and more rapid in the future. Personalized medicine, tailoring pharmacologic and behavioral therapy to an individual's genetic code, is an emerging practice. Applications of research regarding the genetics of eating behavior may lead to the individualization of therapies targeting specific genetic mutations and behavioral interventions addressing eating behaviors. For example, once the role of specific gene variants in pathways involved in specific behaviors or food responses are well established, treatment could be individualized toward modifying these behaviors (e.g., carbohydrate craving, unrestrained or binge eating, comfort eating, food addiction) and toward pharmacologic modalities developed to modify the molecular pathways involved. Individuals with a TAS2R38 variant associated with enhanced bitter taste might be counseled to select healthy foods that might be more palatable or instructed regarding methods of food preparation to make bitter vegetables more palatable.While current research is limited, preliminary studies hold promise toward these ends. Authors of a nutra-genomic study involving customized treatment with a nutraceutical based on the study subjects' genetic profile report improvement in weight loss, sugar craving reduction, appetite suppression, snack reduction, and reduction of late-night eating among study participants who received therapy tailored toward their genetic profile. 76 The risk of obesity, metabolic syndrome, and related complications is increased by a variety of common genetic variants, and many of these are associated with specific eating behaviors. Although rare genetic mutations cause dramatic hyperphagia, common genetic variants usually are responsible for smaller effect sizes. It is likely, however, that genetic susceptibility toward aberrant eating behavior and obesity may be overcome by practicing healthy behaviors. This principle was demonstrated among individuals harboring the common TCF7L2 variant, which is associated with increased risk of developing type 2 diabetes mellitus (T2DM). In the Diabetes Prevention Study, individuals with the at-risk variant who were randomized to intense lifestyle interventions including prudent diet, weight loss, and physical activity, demonstrated reduced progression to T2DM in spite of their genetic predisposition. 77 Studies involving FTO variants also demonstrate that genetic predispositions to obesity can be overcome by prudent diet and exercise. 78, 79 With additional research, individuals and physicians will have more tools to help identify susceptible individuals and to guide therapy and treatment. The study of the genetics of eating behavior and its interplay with obesity is progressing rapidly, and new techniques, including FMRI, are changing how behavioral research is performed and providing new insights into the mechanisms of eating behavior. While it is currently premature to know if developing pharmacologic therapies targeting the A1 allele of TAQ1A or other alleles discussed in this review will contribute to substantial changes in eating behavior or weight loss treatment, it may be helpful, nevertheless, for individuals to become aware of their genetic susceptibilities and to practice prudent nutritional behaviors before they become overweight or obese.
